You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Boehringer Ingelheim
Moodys
Baxter
Colorcon

Last Updated: May 8, 2021

DrugPatentWatch Database Preview

ALBUMINAR-25 Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: ALBUMINAR-25
Recent Litigation for ALBUMINAR-25

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Genentech, Inc. v. Samsung Bioepis Co. Ltd.2020-06-28
ABRAXIS BIOSCIENCE, LLC v. SUN PHARMA ADVANCED RESEARCH COMPANY, LTD.2019-08-08
Genentech, Inc. v. Pfizer Inc.2019-04-05

See all ALBUMINAR-25 litigation

PTAB Litigation
PetitionerDate
Apotex Inc.2017-11-09
Cipla Ltd.2017-11-09
Actavis LLC2017-04-04

See all ALBUMINAR-25 litigation

Patent Text Search: US Patents for ALBUMINAR-25

These patents were identified by searching patent claims

Supplementary Protection Certificates for ALBUMINAR-25

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2009C/046 Belgium   Get Started for $10 PRODUCT NAME: PACLITAXEL ALBUMIN; AUTHORISATION NUMBER AND DATE: EU/1/07/428/001 20080111
C01463751/01 Switzerland   Get Started for $10 PRODUCT NAME: ALBIGLUTIDUM; REGISTRATION NO/DATE: SWISSMEDIC 63223 29.09.2014
238 50005-2014 Slovakia   Get Started for $10 PRODUCT NAME: PAKLITAXEL VO FORME NANOCASTIC VIAZANYCH NA ALBUMIN; REGISTRATION NO/DATE: EU/1/07/428/001 - EU/1/07/428/002 20131230
132014902293932 Italy   Get Started for $10 PRODUCT NAME: ALBIGLUTIDE(EPERZAN); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/13/908, 20140321
132014902271575 Italy   Get Started for $10 PRODUCT NAME: PACLITAXEL LEGATO ALL'ALBUMINA FORMULATO IN NANOPARTICELLE(ABRAXANE); AUTHORISATION NUMBER(S) AND DATE(S): EU/01/07/428, 20131220
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Colorcon
Dow
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.